Please login to the form below

Not currently logged in
Email:
Password:

True North Therapeutics

This page shows the latest True North Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

north of $1bn in 2017 - as well as a pipeline of blood disorder products. ... Since splitting off from Biogen, Bioverativ has added to its pipeline by buying True North Therapeutics for $825m last May, a deal which brought in lead pipeline candidate

Latest news

  • Biogen spin-out makes first acquisition Biogen spin-out makes first acquisition

    Biogen spin-out makes first acquisition. Bioverativ attains rare disease group True North. ... Just three months after splitting from Biogen, Bioverativ has inked its first major deal adding a new clinical candidate to its pipeline via a $825m deal to

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • BioMarin’s chief commercial officer joins True North’s board BioMarin’s chief commercial officer joins True North’s board

    California, US-based biotech True North Therapeutics has appointed Jeff Ajer to its board of directors as an independent director. ... Nancy Stagliano, chief executive officer of True North Therapeutics, said: “ We are delighted that Jeff has joined

  • Amgen finance VP joins True North Therapeutics Amgen finance VP joins True North Therapeutics

    Amgen finance VP joins True North Therapeutics. Pamela Wapnick appointed as chief financial officer. ... California-based True North Therapeutics has appointed Pamela Wapnick as its new chief financial officer.

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Lars Bruening
Shaping healthcare
Bayer’s Lars Bruening talks about moving to the UK as the market works its way through a series of seismic changes...
No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...

Infographics